Journals / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 3

The Role of Latent Toxoplasmosis in Alzheimer’s Disease

Pages
380–383
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, T. gondii infection could not be considered having any role in AD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aimed to investigate whether there was any role of latent toxoplasmosis in Alzheimer’s disease (AD).Methods: Forty-four patients with the probable AD and 30 healthy individuals were included in this prospective study.The patient and healthy groups were matched by sex, age, dietary habits and socioeconomic status.
📊
Key Findings & Data:T. gondii IgG antibody in all individuals was studied by enzyme-linked immune sorbent assay method.Results: The present study consisted of 44 patients with the probable AD with 25 male and 19 female, and 30 healthyindividuals with 19 male and 11 female.
💡
Conclusion & Impact:Thus, T. gondii infection could not be considered having any role in AD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aimed to investigate whether there was any role of latent toxoplasmosis in Alzheimer’s disease (AD).Methods: Forty-four patients with the probable AD and 30 healthy individuals were included in this prospective study.The patient and healthy groups were matched by sex, age, dietary habits and socioeconomic status. T. gondii IgG antibody in all individuals was studied by enzyme-linked immune sorbent assay method.Results: The present study consisted of 44 patients with the probable AD with 25 male and 19 female, and 30 healthyindividuals with 19 male and 11 female. The mean age of the patients was 78.18±8.95 years, and the control group was74.33±7.89 years. It was not found statistically significant difference in age and gender between patients and healthyindividuals (p=0.06 and p=0.58, respectively). The percentages of T. gondii IgG antibody positivity were 71% for the patients with probable AD and 67% for the healthy individuals. The difference in T. gondii IgG antibody positivity betweenthe Alzheimer and the healthy control group was not statistically significant (p=0.73).Conclusion: These findings showed that there was no association between toxoplasmosis and AD. Thus, T. gondii infection could not be considered having any role in AD.

🔖

Cite This Article

KARABULUT, N., KARABOĞA, F., SUBAŞI, B. (2022). The Role of Latent Toxoplasmosis in Alzheimer’s Disease. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 3, 380–383. https://ajindex.com/articles/508628

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. World population ageing 2013. United Nations, Department of Economic and Social Affairs, Population Division 2013
  2. Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine 2012;2
  3. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimer's & dementia: the journal of the Alzheimer's Association 2009;5:348–60
  4. Park MH, Kwon YJ, Jeong HY, Lee HY, Hwangbo Y, Yoon HJ, et al. Association between Intracellular Infectious Agents and Schizophrenia. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology 2012;10:117–23
  5. Karabulut N. Toxoplasma and Schizophrenia. Türk Mikrobiyol Cem Derg 2013;43:39–44
  6. Fabiani S, Pinto B, Bruschi F. Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship? Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2013;34:417–25
  7. Freidel S, Martin-Solch C, Schreiter-Gasser U. [Alzheimer's dementia or cerebral toxoplasmosis? Case study of dementia following toxoplasmosis infection]. Der Nervenarzt 2002;73:874–8
  8. Prandota J. Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis. Research in Autism Spectrum Disorders. 2011;5:14–59
  9. Karabulut N, Bilgic S, Gurok MG, Karaboga F. Is there any role of latent toxoplasmosis in schizophrenia disease? Journal of the Chinese Medical Association: JCMA 2015;78:533–7
  10. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample. Schizophrenia bulletin 2007;33:789–91
  11. Pedersen MG, Stevens H, Pedersen CB, Norgaard-Pedersen B, Mortensen PB. Toxoplasma infection and later development of schizophrenia in mothers. The American journal of psychiatry 2011;168:814–21
  12. Kamerkar S, Davis PH. Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection. Journal of parasitology research 2012;2012:589295
  13. Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophrenia bulletin 2012;38:642–7
  14. Kusbeci OY, Mim